Late gadolinium-enhanced cardiac magnetic resonance

被引：12

作者：

Lin D. ^{[1
]}

Kramer C.M. ^{[1
]}

机构：

[1] Departments of Medicine and Radiology, University of Virginia Health System, Charlottesville, VA 22908

来源：

Current Cardiology Reports | 2008年 / 10卷 / 1期

关键词：

Single Photon Emission Compute Tomography; Right Ventricular; Cardiovascular Magnetic Resonance; Pulmonary Arterial Hypertension; Late Gadolinium Enhancement;

D O I：

10.1007/s11886-008-0014-4

中图分类号：

学科分类号：

摘要：

Recent advances in cardiovascular magnetic resonance have made it an important clinical tool. Late gadolinium enhancement imaging after gadolinium administration is now a well-validated and practical test to assess myocardial scarring. Due to its high spatial resolution, late gadolinium enhancement is much more sensitive in detecting small infarctions than older imaging modalities. However, late gadolinium enhancement is not specific for myocardial infarction but can occur in a number of cardiomyopathies. New studies suggest that the extent and pattern of enhancement may have prognostic and therapeutic implications, making it an important non-invasive instrument in cardiovascular diagnostics. © Current Medicine Group LLC 2008.

引用

页码：72 / 78

页数：6

共 53 条

[1]

Risk stratification and survival after myocardial infarction [no authors listed], N Engl J Med, 309, pp. 331-336, (1983)

[2]

Steen H., Giannitsis E., Futterer S., Et al., Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function, J Am Coll Cardiol, 48, pp. 2192-2194, (2006)

[3]

Wagner A., Mahrholdt H., Holly T.A., Et al., Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study, Lancet, 361, pp. 374-379, (2003)

[4]

Assomull R.G., Prasad S.K., Lyne J., Et al., Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy, J Am Coll Cardiol, 48, pp. 1977-1985, (2006)

[5]

Moon J.C., McKenna W.J., McCrohon J.A., Et al., Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance, J Am Coll Cardiol, 41, pp. 1561-1567, (2003)

[6]

Kwong R.Y., Chan A.K., Brown K.A., Et al., Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease, Circulation, 113, pp. 2733-2743, (2006)

[7]

Allman K.C., Shaw L.J., Hachamovitch R., Et al., Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis, J Am Coll Cardiol, 39, pp. 1151-1158, (2002)

[8]

Hombach V., Grebe O., Merkle N., Et al., Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging, Eur Heart J, 26, pp. 549-557, (2005)

[9]

Wu K.C., Zerhouni E.A., Judd R.M., Et al., Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction, Circulation, 97, pp. 765-772, (1998)

[10]

Bleeker G.B., Kaandorp T.A., Lamb H.J., Et al., Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy, Circulation, 113, pp. 969-976, (2006)

← 1 2 3 4 5 6 →